CGNX.NASDAQCognex CORP

Form 4: Cognex Director Sells Shares After RSU Vesting

Sentiment:

Insider Transaction Report


Cognex Director Angelos Papadimitriou sold 4,150 shares of common stock for $55.5804 each after exercising 2,537 restricted stock units.

Worse than expectedThe director sold 4,150 shares of common stock, reducing their direct ownership. While this followed the exercise of RSUs, the net effect is a reduction in shares held by an insider.

Summary

  • Angelos Papadimitriou, a Director at Cognex Corp (CGNX), reported two transactions.
  • On February 21, 2026, Papadimitriou acquired 2,537 shares of Cognex common stock through the exercise of restricted stock units (RSUs) at a price of $0.0.
  • These RSUs vested on the third anniversary of their grant date, February 21, 2023.
  • Following this acquisition, Papadimitriou directly owned 20,372 shares of common stock.
  • On February 23, 2026, Papadimitriou sold 4,150 shares of Cognex common stock at a price of $55.5804 per share.
  • After the sale, Papadimitriou directly owns 16,222 shares of common stock.
  • Papadimitriou also holds 4,817 restricted stock units that are scheduled to vest on February 17, 2027.

Sentiment

Score: 4

Explanation: StockSavvy.ai views this as a slightly negative signal. A director selling shares, even if part of a pre-planned RSU exercise and sale, can be interpreted as a minor reduction in insider confidence, though the overall impact is limited given the context of compensation.

Positives

  • The vesting and exercise of 2,537 restricted stock units indicate a planned compensation event for the director.
  • The director continues to hold a significant number of shares (16,222 common shares) and additional unvested restricted stock units (4,817), demonstrating continued alignment with shareholder interests.

Negatives

  • The sale of 4,150 shares by a director, even after an RSU exercise, reduces insider ownership and could be perceived negatively by the market.

Future Outlook

No specific future outlook or guidance is provided in this insider transaction report.

Industry Context

StockSavvy.ai notes that insider transactions, particularly sales, are closely watched by investors for signals regarding management's confidence in the company's future prospects. While this is a routine RSU vesting and subsequent sale, it occurs within the broader context of the industrial automation and machine vision industry where Cognex operates.

Related Party Transactions

  • The filing details transactions by a director, Angelos Papadimitriou, who is considered a related party to Cognex Corp.

Stakeholder Impact

  • Shareholders: The sale by a director could be perceived as a minor negative signal, potentially influencing investor sentiment.

Next Steps

  • The remaining 4,817 restricted stock units are scheduled to vest on February 17, 2027.

Key Dates

DateDescription
02/21/2023Grant date of restricted stock units.
02/21/2024First vesting anniversary of restricted stock units.
02/21/2026Third vesting anniversary and exercise date of 2,537 restricted stock units.
02/23/2026Date of common stock sale.
02/17/2027Vesting date for remaining 4,817 restricted stock units.

Recommendation

hold

While the director's sale of shares might be seen as a slight negative, it followed a routine RSU vesting, suggesting it could be for personal liquidity or diversification rather than a lack of confidence in the company's fundamentals. The director still retains a substantial holding, indicating continued alignment. Without further context on Cognex's performance or industry trends, a 'hold' recommendation is appropriate, advising investors to monitor future insider activity and company performance.

Keywords

Cognex, CGNX, Form 4, Insider Trading, Director Stock Sale, Restricted Stock Units, RSU Exercise, Stock Transaction, Angelos Papadimitriou

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.